November 2025
The global alpha-1 antitrypsin deficiency augmentation therapy market size is estimated to hit around USD 2.96 billion by 2034 from USD 1.84 billion in 2026, at a CAGR of 6.14%.
January 2026
The global iron deficiency anemia therapy market size is projected to be worth around USD 10.42 billion by 2035 from USD 5.47 billion in 2025 at a CAGR of 6.66%.
September 2026
The global in vivo CAR-T therapy market size was evaluated at USD 861.25 million in 2026 and is predicted to hit around USD 10,841.07 million by 2035, growing at a CAGR of 32.50%.
June 2026
The global phage therapy market size is evaluated at USD 1.29 billion in 2025 and is predicted to hit around USD 1.92 billion by 2035, growing at a CAGR of 4.06%.
June 2026
The global oncolytic virus therapy market size is evaluated at USD 3.71 billion in 2025 and is predicted to hit around USD 12.31 billion by 2035, growing at a CAGR of 12.74%.
June 2026
The global AAV gene therapy market size was evaluated at USD 2.85 billion in 2025 and is predicted to hit around USD 27.41 billion by 2035, with a CAGR of 25.39%.
June 2026
The global cell therapy manufacturing market size was valued at USD 5.55 billion in 2025 and is projected to hit around USD 21.02 billion by 2035 with a CAGR of 14.24%.
June 2026
The U.S. stem cell therapy market size reached USD 6.75 billion in 2025 and is projected to hit around USD 21.31 billion by 2035 with a remarkeble CAGR of 12.18%.
May 2026
The global automated and closed cell therapy market size is estimated to hit around USD 12.9 billion by 2035 increasing from USD 1.86 billion in 2025, with a CAGR of 21.37%.
May 2026
The global oxygen therapy market size was calculated at USD 41.63 billion in 2025 and is projected to hit around USD 70.01 billion by 2035 with a CAGR of 5.34%.
February 2026
The global brachytherapy market size awas valued at USD 1.07 billion in 2025 and is estimated to be worth around USD 2.12 billion by 2035 at a CAGR of 7.08%.
February 2026
The global light therapy market size reached USD 1.16 billion in 2025 and is projected to hit around USD 1.72 billion by 2035, growing at a CAGR of 4.02%.
July 2025
The physiotherapy services market size is estimated to surpass around USD 97.11 billion by 2034 increasing from USD 57.91 billion in 2024, growing at a CAGR of 5.31%.
September 2026
The global continuous renal replacement therapy consumables market size was evaluated at USD 997.83 million in 2026 and is predicted to hit around USD 2,069.01 million by 2035, growing at a CAGR of 8.44%.
September 2026
The global obesity GLP-1 market size was evaluated at USD 10.12 billion in 2026 and is predicted to hit around USD 66.57 billion by 2035, growing at a CAGR of 23.28%.
September 2026
The global cell and gene therapy market size was calculated at USD 10.44 billion in 2026 and is projected to surpass around USD 47.18 billion by 2035 with a solid CAGR of 18.1%.
September 2026
The photothermal therapy patches market size stood at USD 295.83 billion in 2026, with major photothermal therapy patches market companies including Photothermal Therapeutics Inc., NanoHybrids Inc., BioCure Technology Inc.
September 2026
The global PD-1 inhibitor drugs market size was estimated at USD 56.29 billion in 2026 and is expected to hit around USD 201.87 billion by 2035, growing at a CAGR of 15.28% from 2026 to 2035.
September 2026
The global hormone replacement therapy market size is projected to hit around USD 70.63 billion by 2035 from USD 42.02 billion in 2026 with a notable CAGR of 5.95%.
September 2026
The global shock wave therapy market size is calculated at USD 2.57 billion in 2026 and is projected to hit around USD 6.48 billion by 2035 with a CAGR of 10.82%.
September 2026
The global radiotherapy market size is calculated at USD 9.10 billion in 2026 and is projected to hit around USD 15.56 billion by 2035 with a CAGR of 6.16%.
September 2026
The global combination antibody therapy market size is estimated to hit around USD 700.59 billion by 2035 increasing from USD 268.17 billion in 2026, with a CAGR of 11.26%.
September 2026
The cell therapy market size reached USD 9.13 billion in 2026, with leading cell therapy market companies including cell therapy , Cells for Cells, Celgene Corporation.
September 2026
The global cardiac resynchronization therapy market size is projected to hit around USD 18.33 billion by 2035 from USD 9.73 billion in 2026 with a CAGR of 7.31%.
September 2026
The global exosome-based cancer therapy CDMO market is growing as demand rises for scalable manufacturing and delivery solutions in exosome therapeutics.
September 2026
The global aromatherapy market size surpassed USD 11.10 billion in 2026 and is estimated to reach around USD 23.31 billion by 2035, expanding at a CAGR of 8.61%.
September 2026
The stem cell therapy market size is expected to increase from USD 20.53 billion in 2026 and it is predicted to hit USD 59.70 billion by 2035 at a CAGR of 12.66%.
September 2026
The global image-guided therapy systems market size is projected to hit around USD 11.22 billion by 2035 from USD 6.84 billion in 2026 with a notable CAGR of 5.66%.
September 2026
The home infusion therapy market size was valued at USD 45.23 billion in 2026 and is projected to hit around USD 90.65 billion by 2035 with a CAGR of 8.04%.
September 2026
The global oncolytic virus-based gene therapy market is growing rapidly as viral vectors are engineered to selectively target and destroy cancer cells.